Jochen B.
- Country
- Norway
- Department
- Department of Pediatric Hematology and Oncology
Research Overview
- Phase III Randomized Trial Comparing Clofarabine, Fludarabine, and Busulfan vs. Busulfan, Cyclophosphamide, and Melphalan in Pediatric Acute Myeloid Leukemia Transplant Conditioning
- Phase I/II Evaluation of Inotuzumab Ozogamicin Monotherapy and Combined Chemotherapy in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia
- International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children - Sub-protocol D
Data & Insights
Has run more than one trial at 87 of 173 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating children with acute myeloid leukemia (AML), focusing on advanced therapeutic approaches in pediatric blood cancers.
- Childhood Leukemia Management
- Blood Cancer Therapeutics
- Pediatric Cancer Care
Their clinical expertise extends to specialized treatment protocols for young patients with hematologic malignancies.
Transplantation Medicine
The investigator has developed expertise in pediatric stem cell transplantation and conditioning regimens for young patients with blood disorders.
- Transplant Protocols
- Conditioning Strategies
- Treatment Optimization
Their work encompasses innovative approaches to transplantation procedures in pediatric populations.
Treatment Outcomes
The investigator focuses on improving long-term survival outcomes and reducing complications in pediatric cancer treatment.
- Survival Rate Enhancement
- Complication Prevention
- Quality of Life Improvement
Their research aims to advance treatment effectiveness while minimizing adverse effects in young patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.